Royal London Asset Management
MDCO

Royal London Asset Management’s Medicines Co MDCO Stock Holding History

Royal London Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$1.99M Buy
+59,061
New +$2.08M 0.03% 465
2016
Q1 		– Sell
-41,065
Closed -$1.54M – 553
2015
Q4 		$1.54M Sell
41,065
-255
-0.6% -$9.64K 0.02% 506
2015
Q3 		$1.57M Buy
+41,320
New +$1.45M 0.03% 510

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal London Asset Management's MDCO Position: Q2 2016 in Review

Royal London Asset Management opened a new position in Medicines Co (MDCO) in Q2 2016: 59,061 shares worth $1.99M. The stake represents 0.03% of the portfolio and ranks #465 among its holdings. This is a return to the name: Royal London Asset Management previously reported a position in MDCO as recently as Q4 2015.

Royal London Asset Management first reported a position in MDCO in Q3 2015 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold MDCO as of Q2 2016.

  • Royal London Asset Management held 59,061 shares of Medicines Co worth $1.99M as of Q2 2016.
  • Medicines Co was a new Royal London Asset Management position in Q2 2016.
  • Medicines Co made up 0.03% of Royal London Asset Management's portfolio in Q2 2016, its #465 holding.
  • Royal London Asset Management first reported a position in Medicines Co in Q3 2015 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q2 2016.

Based on Royal London Asset Management's 13F filing for Q2 2016, filed 2 Aug 2016.